乳腺癌治疗之旅

Your mom will always fight for you, and you should always fight for her. Dr. Duc works as a radiologist in a notable hospital within Vietnam. His mother was diagnosed with stage IV adenocarcinoma of the lung with spine metastasis, and his world changed forever. Here is Dr. Duc and his mother’s story with ECCT: Dr. Duc’s mother was suffering from poor appetite and a loss of taste from the stage IV cancer while the spine metastasis was causing severe pain. During her first meeting with a doctor, she was told that her cancer had advanced to an aggressive stage and she had roughly six months to live. Dr. Duc could not accept this, even though he is a medical doctor but he could not save his own mother’s life. He was indeed sad but he was determined to find another solution. By connecting with the board members of Revotera, Dr.Duc’s mother obtained a second chance through ECCT. Her incredible story with ECCT starts here, and Dr. Duc was overjoyed to see his mother's condition improving each day. Her appetite came back, she was able to enjoy food again, and her pain was relieved. During follow-up visits, her oncologist was surprised with her improvement and even mentioned to Dr. Duc that most patients may not have made it. Eleven months after the initial ECCT treatment, the positive difference in her health was astounding.  Dr. Duc’s mother improved significantly and her cancer began to subside. She was able to perform all activities of daily living and her physical health and strength improved, as well. Previously, she could only walk for 100m. Now, she can walk up to 1km at a time. The frequency of ECCT worked for Dr. Duc’s mother. She used ECCT for 30 minutes per day for one month, and then increased to 60 minutes twice per day. Following, she used the ECCT device for 90 minutes after six months. The positive effects were clear. ECCT made the difference and gave Dr. Duc’s mother her life back. Dr. Duc’s mother is currently healthy and thriving. Looking at his mother's smile every day, Dr. Duc continues to feel humbled and moved by the positive effects that ECCT had on his mother’s treatment.

Learn how oncologists balance treating breast cancer during pregnancy with ensuring the health of the fetus, focusing on personalized, multidisciplinary care. Breast Cancer During Pregnancy: Balancing Fetal Health with Oncology Care Section Title Breast cancer during pregnancy is rare but presents a challenging situation for both the mother and her medical team. The dual concern of treating cancer while ensuring the health of the developing fetus requires a multidisciplinary approach, with oncologists, obstetricians, and pediatricians working closely together. Diagnosing breast cancer during pregnancy is complicated because breast tissue undergoes changes that can mask lumps or other symptoms. This can result in delayed diagnoses, making the cancer more advanced by the time it is detected. Treatment must be carefully timed to minimize risks to the fetus. Surgery to remove the tumor is generally considered safe during all trimesters of pregnancy, and in many cases, it is the first step. Chemotherapy, on the other hand, is usually avoided during the first trimester, as it could harm the developing baby. However, it may be administered during the second and third trimesters when the risk is lower. Radiation therapy and certain targeted therapies are typically postponed until after delivery due to the potential risks to the fetus. ECCT provides a relatively safe and non-invasive cancer treatment during pregnancy, and most importantly does not harm to the fetus. The emotional and psychological toll on pregnant women facing cancer treatment is immense. Many mothers struggle with feelings of guilt or fear about the potential impact on their baby. Having a robust support system, including mental health professionals, can be critical in helping women navigate this difficult experience. Post-treatment, breastfeeding may also be affected depending on the surgery and treatments undergone, so new mothers often need specialized advice. Managing breast cancer during pregnancy requires a delicate balance, and ongoing research aims to improve treatment protocols to optimize outcomes for both mother and baby.

Understanding blood parameters during chemotherapy is a crucial part of your care plan. While chemotherapy can impact various aspects of your blood and organ functions, being aware of these changes empowers you to take proactive steps towards your well-being. Understanding blood parameters during chemotherapy is a crucial part of your care plan. While chemotherapy can impact various aspects of your blood and organ functions, being aware of these changes empowers you to take proactive steps towards your well-being: Hemoglobin (Hb) and Red Blood Cells (RBC): White Blood Cells (WBC): Red Blood Cells (RBC): Platelets: Liver Function: Albumin: ALT (Alanine Aminotransferase) AST (Aspartate Aminotransferase): ALP (Alkaline Phosphatase): Kidney Function: Sodium (Na) and Potassium (K): Urea and Creatinine: Calcium (Ca): Glucose: Chemotherapy might affect bone marrow function, potentially leading to decreased red blood cell production and hemoglobin levels. This awareness helps in managing anemia-related symptoms like fatigue, weakness, and shortness of breath. Chemotherapy-induced myelosuppression might lower white blood cell counts, impacting your body's ability to fight infections as the body's ability to fight off pathogens is compromised. Being informed allows you to take preventive measures to reduce infection risks. Chemotherapy-induced myelosuppression may result in a decrease in red blood cell production, contributing to anemia. Therapy can cause thrombocytopenia, reducing platelet counts and increasing the risk of bleeding, bruising, and prolonged clotting problem. Monitoring this parameter helps in timely intervention to maintain healthy blood clotting functions. Chemotherapy may influence liver function, impacting markers like albumin, globulin, ALT, AST, and ALP levels. Regular monitoring helps in detecting and managing any liver-related issues effectively. Chemotherapy may impact the liver's ability to synthesize albumin, leading to decreased levels. Low albumin levels can affect fluid balance. Chemotherapy drugs can cause hepatotoxicity, resulting in elevated levels of ALT and AST. Monitoring these markers helps assess liver function. Elevated ALP levels may indicate liver damage induced by certain chemotherapy agents. It can be a marker of cholestasis or liver cell damage. Observing sodium, potassium, urea, creatinine, calcium, and glucose levels is vital in monitoring kidney function and electrolyte balance during chemotherapy. This allows for proactive measures to maintain optimal kidney health and manage any potential imbalances. Electrolyte imbalances, including changes in sodium and potassium levels, may occur with certain chemotherapy drugs, leading to symptoms such as weakness or irregular heartbeats. Chemotherapy can affect kidney function, leading to an increase in urea and creatinine levels. Elevated levels may indicate impaired renal function. Some chemotherapy drugs, particularly those used for bone-related cancers, may impact calcium levels. Some cancers, especially those that have spread to the bones (bone metastases), can release calcium into the bloodstream as the bones are broken down. Some cancers produce substances, such as parathyroid hormone-related protein (PTHrP), which can increase calcium levels by stimulating the release of calcium from bones. Certain cancers may affect the kidneys' ability to regulate calcium levels, leading to an increase in calcium in the blood. Cancer patients may experience dehydration due to various factors, and this can contribute to elevated calcium levels in the blood. Hence, monitoring the calcium level in the blood test is essential to detect any abnormalities. Chemotherapy may influence glucose metabolism. Some drugs can lead to changes in blood glucose levels, potentially affecting patients with or without pre-existing diabetes.

ECCT - An Effective Alternative and Complementary Cancer Treatment

Describe your service here. What makes it great? Use short catchy text to tell people what you offer, and the benefits they will receive. A great description gets readers in the mood, and makes them more likely to go ahead and book.

Describe your service here. What makes it great? Use short catchy text to tell people what you offer, and the benefits they will receive. A great description gets readers in the mood, and makes them more likely to go ahead and book.

Describe your service here. What makes it great? Use short catchy text to tell people what you offer, and the benefits they will receive. A great description gets readers in the mood, and makes them more likely to go ahead and book.